Vital Signs - Expediting time to market: How laboratory developed tests have expanded the IVD markets

 


This issue of Vital Signs, released on April 12, 2010, provides a strategic overview of how laboratory developed tests
have expanded the IVD markets. Additionally, a company spotlight is provided for Sakura Finetek USA, a global leader for advanced automation systems for anatomic pathology (AP) in both research and diagnostic environments. Reimbursement and regulatory news from the FDA is also provided for the week of March 22, 2010.
USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

Table of Contents

Vital Signs - Expediting time to market: How laboratory developed tests have expanded the IVD marketsVital Signs: 12 April 2010This week's issue:




Related Research

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 24-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.